A successful Phase 3 trial and a public offeringof stock boosted prospects for this company to receive approval for an ...
Like other developing countries, Indonesia is facing a familiar dilemma: how to feed a growing population while protecting ...
Panther is inviting pharmaceutical and biotechnology partners to co-develop higher-efficacy, lower-toxicity, shelf-stable therapies using its MAP platform. We believe rethinking how treatments are ...
Sulfolobus islandicus, an archaeal model organism, offers unique advantages for metabolic engineering and synthetic biology ...
With partner Eli Lilly’s help, the radiopharmaceutical drugmaker priced one of the sector’s largest new stock offerings in ...
On December 19, 2025, the National Security Commission on Emerging Biotechnology (NSCEB) announced the publication of a paper entitled “The Future of U.S.-China Biotechnology Competition.” The paper ...
A French company recently made an announcement that flew a little under the radar in 2025, but North Carolina agriculture ...
24/7 Wall St. on MSN
Biotech Could Be One of 2026’s Biggest Winners, and This ETF Is Perfectly Positioned
Biotech investors spent years waiting for the sector to recover from its brutal 2021 peak. That patience is finally paying ...
TipRanks on MSN
Sana Biotechnology price target raised to $7 from $6 at BofA
BofA raised the firm’s price target on Sana Biotechnology (SANA) to $7 from $6 and keeps a Buy rating on the shares. The firm ...
Here is STAT’s biotech scorecard, our regular ledger of stock-moving biotech events, for the first quarter: Alumis: Top-line ...
Union Minister Dr. Jitendra Singh inaugurated two major biotech initiatives at Hyderabad’s CDFD, the SAMARTH Skill ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback